“Unlocking the Potential of Pyrazines: Structure–Activity Relationship Driven Studies against Mycobacterium tuberculosis” (2026) Asian Journal of Pharmaceutics (AJP), 19(04). doi:10.22377/ajp.v19i04.7057.